Document is current
Any future updates will be listed below
-
Authors
Fujii, Hironori
Tsuchiya, Masami
Watanabe, Daichi
Chin, Miki
Hirate, Daisuke
Takahashi, Katsuyuki
Go, Makiko
Kudo, Toshihiro
Shimomura, Kazuhiro
Ando, Yosuke
Tani, Shinya
Takahashi, Takao
Hayashi, Katsuhisa
Hashimoto, Hironobu
Matsunami, Naomi
Takahashi, Masaya
Hasegawa, Akiko
Uchida, Takashi
Kubo, Akiko
Matsuhashi, Nobuhisa
Suzuki, Akio
Nishimura, Junichi
Inui, Naoki
Iihara, Hirotoshi
- License Information
-
More Information
Article History
Received: 25 November 2024
Accepted: 28 April 2025
First Online: 13 May 2025
Declarations
:
: H Fujii has received honoraria for lectures from Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., and Taiho Pharmaceutical Co., Ltd.M Tsuchiya has received honoraria for lectures from Ono Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Sun Pharm and Kyowa Kirin.D Watanabe has received honoraria for lectures from Chugai Pharmaceutical Co., Ltd.D Hirate has received honoraria for lectures from Taiho Pharmaceutical Co., Ltd., Daiichi Sankyo, Eli Lilly and Company, Pfizer Eisai, Takeda Pharmaceutical Co., Ltd., Bristol Myers Squibb., EA Pharmaceutical Co., Ltd., MSD Japan, Kyowa Kirin, Chugai Pharmaceutical Co., Ltd., Yakult Honsha., Nippon Kayaku., Eisai., Meiji Seika Pharmaceutical Co., Ltd., Merck Bio Pharmaceutical Co., Ltd., AstraZeneca plc. and Sun Pharma.Y Ando has received honoraria for lectures from Yakult Honsha., Taiho Pharmaceutical Co., Ltd., Daiichi Sankyo, and Pfizer Eisai.N Matsunami has received honoraria for lectures from Pfizer Eisai, Daiichi Sankyo and Eli Lilly and Company. N Matsuhashi has received both honoraria for lectures and grants made to the institution from Taiho Pharmaceutical Co., Ltd.J Nishimura has received honoraria for lectures from Taiho Pharmaceutical Co., Ltd.N Inui has received honoraria for lectures from Taiho Pharmaceutical Co., Ltd., AstraZeneca plc and Chugai Pharmaceutical Co., Ltd.A Suzuki has received honoraria for lectures from Toa Eiyo, Asahi Kasei Pharmaceutical Co., Ltd., Daiichi Sankyo, Pfizer Eisai, Nippon Shinyaku, Celltrion Healthcare Japan, Otsuka Pharmaceutical Co., Ltd., Sandoz, Tsumura, Nipro, Taiho Pharmaceutical Co., Ltd., Kyowa Kirin, Nippon Chemiphar, Japan Blood Products Organization, Takeda Pharmaceutical Co., Ltd., and Nippon Boehringer Ingelheim; grants made to institution from Nippon Kayaku, Asahi Kasei Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Daiichi Sankyo, Japan Blood Products Organization, Mochida Pharmaceutical Co., Ltd., Sun Pharma; and consulting fees from Nippon Kayaku.H Iihara has received honoraria for lectures from Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Yakult Honsha., Astellas Pharmaceutical Co., Ltd., Eli Lilly and Company, Daiichi Sankyo., AstraZeneca plc, Nippon Kayaku, Ono Pharmaceutical Co., Ltd., and Nippon Boehringer Ingelheim; and consulting fees from Pfizer Eisai and Taiho Pharmaceutical Co., Ltd.
: The authors declare no competing interests.
